Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 32.67
(0.28%)
CNY 32.67
(0.28%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 99.32 Million CNY | -26.53% |
| 2022 | 135.19 Million CNY | -4.59% |
| 2021 | 141.7 Million CNY | 53.38% |
| 2020 | 92.38 Million CNY | 153.95% |
| 2019 | 36.38 Million CNY | 4.58% |
| 2018 | 34.78 Million CNY | 23.29% |
| 2017 | 28.21 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 76.25 Million CNY | -5.22% |
| 2024 Q1 | 81.51 Million CNY | -17.93% |
| 2024 Q2 | 80.45 Million CNY | -1.29% |
| 2023 Q4 | 99.32 Million CNY | -12.09% |
| 2023 FY | 99.32 Million CNY | -26.53% |
| 2023 Q3 | 112.97 Million CNY | -4.58% |
| 2023 Q2 | 118.39 Million CNY | -15.42% |
| 2023 Q1 | 139.97 Million CNY | 3.54% |
| 2022 Q3 | 203.98 Million CNY | 16.84% |
| 2022 Q2 | 174.58 Million CNY | -14.95% |
| 2022 Q1 | 205.27 Million CNY | 44.86% |
| 2022 FY | 135.19 Million CNY | -4.59% |
| 2022 Q4 | 135.19 Million CNY | -33.72% |
| 2021 Q3 | 102.83 Million CNY | -13.52% |
| 2021 FY | 141.7 Million CNY | 53.38% |
| 2021 Q4 | 141.7 Million CNY | 37.8% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q2 | 118.91 Million CNY | 0.0% |
| 2020 Q4 | 92.38 Million CNY | 0.0% |
| 2020 Q2 | 82.09 Million CNY | 0.0% |
| 2020 FY | 92.38 Million CNY | 153.95% |
| 2020 Q1 | 82.09 Million CNY | 0.0% |
| 2019 FY | 36.38 Million CNY | 4.58% |
| 2018 FY | 34.78 Million CNY | 23.29% |
| 2017 FY | 28.21 Million CNY | 0.0% |